Kilitch Drugs Shows Mixed Technical Trends Amid Strong Long-Term Performance
Kilitch Drugs (India), a microcap in the Pharmaceuticals & Drugs sector, has shown strong performance metrics, with significant returns over three and five years compared to the Sensex. Technical indicators present a mixed outlook, reflecting the company's resilience and growth potential amid current market dynamics.
Kilitch Drugs (India), a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock, currently priced at 400.65, has shown notable performance metrics, including a 52-week high of 425.90 and a low of 271.30. In terms of technical indicators, the weekly MACD and Bollinger Bands are signaling bullish trends, while the monthly indicators present a mixed picture with some mildly bearish signals. The daily moving averages indicate a slightly bearish sentiment, contrasting with the overall bullish outlook from the weekly metrics.
Kilitch Drugs has demonstrated impressive returns compared to the Sensex, particularly over longer periods. Over the past three years, the stock has returned 114.88%, significantly outperforming the Sensex's 40.71%. In the last five years, the return stands at an impressive 287.48%, compared to the Sensex's 145.38%.
These performance indicators highlight Kilitch Drugs' resilience and growth potential within the pharmaceutical sector, showcasing its ability to navigate market fluctuations effectively.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
